newsfilter
← Latest News
PR Newswire·

SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling Cancer

  • SOTERIA Precision Medicine Foundation has announced a collaboration with Tempus to provide personalized cancer treatment insights & advanced genomic sequencing to U.S. active-duty military & veterans.
  • The partnership supports SOTERIA's Cancer Hunt initiative by integrating Tempus' comprehensive genomic profiling & AI-enabled diagnostic platform to identify targeted therapies & clinical trial opportunities.
  • SOTERIA addresses the critical care gap of younger & advanced-stage cancer diagnoses in military communities by offering patient-centric navigation & CLIA-validated germline & somatic sequencing.
  • SOTERIA CEO Julia Civardi stated the collaboration brings state-of-the-art genomic sequencing & AI analytics to transform complex molecular data into actionable treatment options.
  • Tempus Chief Medical Officer Ezra Cohen emphasized the partnership puts cutting-edge genomic insights directly into the hands of clinicians & patients.
  • SOTERIA Chief Community Officer CAPT Rob Newson noted the initiative combines technological innovation with service to support military families.
  • The collaboration aims to streamline molecular profiling & data integration across SOTERIA's patient cohort to advance precision oncology research & optimize care pathways.
  • Inquiries regarding the Cancer Hunt initiative can be made via the provided website links or by contacting SOTERIA's media relations team.
Company
SOTERIA Precision Medicine Foundation
Keywords
SOTERIA Precision Medicine Foundation